Biotech · Private company
Pain Therapeutics
Track this companyFree. Adds Pain Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- PTI-125, 100 mg tabletsPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 100 mg PTI-125Phase 1 · Alzheimer Disease, Early OnsetClinicalTrials.gov · fetched Nov 12, 2026
- 200 mg PTI-125Phase 1 · Alzheimer Disease, Early OnsetClinicalTrials.gov · fetched Nov 12, 2026
- 50 mg PTI-125Phase 1 · Alzheimer Disease, Early OnsetClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- PTI-125 for Mild-to-moderate Alzheimer's Disease PatientsPHASE2 · COMPLETED · started Mar 7, 2019ClinicalTrials.gov NCT03748706 · fetched Nov 12, 2026
- A Safety Study of PTI-125 in Healthy VolunteersPHASE1 · COMPLETED · started Aug 18, 2017ClinicalTrials.gov NCT03784300 · fetched Nov 12, 2026